Compile Data Set for Download or QSAR

Found 1 hit Enz. Inhib. hit(s) with Target = 'UDP-3-O-acyl-N-acetylglucosamine deacetylase' and Ligand = 'BDBM476342'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
UDP-3-O-acyl-N-acetylglucosamine deacetylase ()	BDBM476342 (US10875832, Compound 97) Show SMILES Oc1c(CNc2ccc(cc2)C#CC#Cc2ccc(cc2)C(=O)N2CCOCC2)nc[nH]c1=O Show InChI InChI=1S/C26H22N4O4/c31-24-23(28-18-29-25(24)32)17-27-22-11-7-20(8-12-22)4-2-1-3-19-5-9-21(10-6-19)26(33)30-13-15-34-16-14-30/h5-12,18,27,31H,13-17H2,(H,28,29,32)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	55	n/a	n/a	n/a	n/a	n/a	n/a
FORGE THERAPEUTICS, INC. US Patent					Assay Description LpxC inhibition assays were performed using liquid chromatography with tandem mass spectrometry. Assays were performed, in duplicate, in opaque, 96-w...				US Patent US10875832 (2020) BindingDB Entry DOI: 10.7270/Q2SX6H9K
					More data for this Ligand-Target Pair